Literature DB >> 19278801

Increased risk of colonic neoplasia in patients with sporadic duodenal adenoma.

S Lagarde1, M Dauphin, C Delmas, F Vitry, O Bouché, G Thiéfin, M D Diebold, G Cadiot.   

Abstract

BACKGROUND: Recent studies have shown an increased risk of colorectal neoplasia in patients with duodenal neoplasia. The aim of this retrospective case-control study was to confirm this risk. PATIENTS AND METHODS: Rate of colorectal neoplasia in 29 patients with one or more duodenal adenomas were compared with controls matched for gender and age, but without duodenal adenomas (one case to two controls). Patients with neoplasia of the ampulla, familial adenomatous polyposis or other known hereditary conditions of the digestive tract were excluded. Indications for upper and lower gastrointestinal endoscopy in controls were abdominal pain or changes in bowel habits. Controls with anemia or digestive bleeding were not included. Neoplastic lesions found at colonoscopy were classified as adenomas, advanced adenomas (size > or =10 mm, villous component, high-grade dysplasia), cancers and advanced neoplasia (cancers and advanced adenomas). Comparison between groups was by Fisher's exact test or Student's t test. Odds-ratios (OR) and 95% confidence intervals were calculated, if the difference was significant.
RESULTS: Mean age of the 29 cases (seven women, 22 men) was 63.2 years and that of the 58 controls (14 women, 44 men) was 62.5 years. First-degree family history of colorectal cancer was present in four cases (13.8%) and eight controls (13.8%) (NS). Colonoscopy showed at least one adenoma in 15 cases (51.7%) and 11 controls (19%) (P=0.0027; OR 1.87, 1.0-3.49), advanced adenomas in four cases (13.8%) and three controls (5.2%) (NS), and colonic adenocarcinoma in three cases (10.3%) and no controls (0%) (P=0.03). Advanced neoplasia was present in seven cases (24.1%) and three controls (5.2%) (P=0.014; OR 2.86, 0.96-8.52). Results were not significantly modified after the exclusion of patients with a family history of colorectal cancer.
CONCLUSION: Although lacking in statistical power, these results confirm that patients with sporadic duodenal adenoma are at high risk of colonic adenoma and advanced neoplasia, warranting systematic colonoscopy.

Entities:  

Mesh:

Year:  2009        PMID: 19278801     DOI: 10.1016/j.gcb.2008.10.018

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  7 in total

1.  Epidemiology of cancer of the small intestine.

Authors:  Sai Yi Pan; Howard Morrison
Journal:  World J Gastrointest Oncol       Date:  2011-03-15

2.  Duodenal adenomas coincide with colorectal neoplasia.

Authors:  Robert M Genta; Jennifer M Hurrell; Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2014-04-06       Impact factor: 3.199

3.  Increased prevalence of colorectal neoplasia in korean patients with sporadic duodenal adenomas: a case-control study.

Authors:  Woo Chul Chung; Bo-In Lee; Sang Young Roh; Jae Wuk Kwak; Sun-Mee Hwang; Yoon Ho Ko; Jung-Hwan Oh; Hyunjung Cho; Hiun-Suk Chae; Young-Seok Cho
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

Review 4.  Non-familial double malignancy of the colon and ampulla of Vater: a case report and review of literature.

Authors:  Rajesh Rajalingam; Amit Javed; Ranjana Gondal; Asit Arora; Hirdaya H Nag; Anil K Agarwal
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485

5.  Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis.

Authors:  Zhen-Jie Wu; Yuan Lin; Jun Xiao; Liu-Cheng Wu; Jun-Gang Liu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

Review 6.  Methods and outcome of the endoscopic treatment of ampullary tumors.

Authors:  Jan-Werner Poley; Sara Campos
Journal:  Ther Adv Gastrointest Endosc       Date:  2020-01-21

7.  Multiple adenomatous duodenal polyposis.

Authors:  Zdena Zádorová; Jan Hajer; Václav Mandys
Journal:  Case Rep Gastrointest Med       Date:  2013-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.